67 related articles for article (PubMed ID: 20417568)
21. Dominant Optic Atrophy: How to Determine the Pathogenicity of Novel Variants?
Zehden JA; Raviskanthan S; Mortensen PW; Ferré M; Reynier P; Milea D; Lee AG
J Neuroophthalmol; 2022 Jun; 42(2):149-153. PubMed ID: 34629404
[No Abstract] [Full Text] [Related]
22. Long-Term Follow-Up Study of Autosomal Dominant Optic Atrophy in an Australian Population.
Chang JH; Jang JD; Jamieson RV; Grigg JR
Asia Pac J Ophthalmol (Phila); 2012; 1(2):88-90. PubMed ID: 26107129
[TBL] [Abstract][Full Text] [Related]
23. OPA1 Mutation Presenting as Ethambutol-Induced Optic Neuropathy.
Jain A; Nashi S; Mailankody P; Srijithesh PR; Kulkarni GB; Alladi S; Bhatia S; Arunachal G
Ann Indian Acad Neurol; 2024 May; 27(3):340-343. PubMed ID: 38835165
[No Abstract] [Full Text] [Related]
24. Establishing induced pluripotent stem cell lines from two dominant optic atrophy patients with distinct
Pohl KA; Zhang X; Pham AH; Chan JW; Sadun AA; Yang XJ
Front Genet; 2023; 14():1251216. PubMed ID: 37745862
[TBL] [Abstract][Full Text] [Related]
25. Dominant Optic Atrophy (DOA): Modeling the Kaleidoscopic Roles of OPA1 in Mitochondrial Homeostasis.
Del Dotto V; Carelli V
Front Neurol; 2021; 12():681326. PubMed ID: 34177786
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial Structure and Bioenergetics in Normal and Disease Conditions.
Protasoni M; Zeviani M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435522
[TBL] [Abstract][Full Text] [Related]
27. Whole genome sequencing unveils genetic heterogeneity in optic nerve hypoplasia.
Dahl S; Pettersson M; Eisfeldt J; Schröder AK; Wickström R; Teär Fahnehjelm K; Anderlid BM; Lindstrand A
PLoS One; 2020; 15(2):e0228622. PubMed ID: 32040484
[TBL] [Abstract][Full Text] [Related]
28. Optic neuropathies: the tip of the neurodegeneration iceberg.
Carelli V; La Morgia C; Ross-Cisneros FN; Sadun AA
Hum Mol Genet; 2017 Oct; 26(R2):R139-R150. PubMed ID: 28977448
[TBL] [Abstract][Full Text] [Related]
29. Genetic and Clinical Analyses of DOA and LHON in 304 Chinese Patients with Suspected Childhood-Onset Hereditary Optic Neuropathy.
Li Y; Li J; Jia X; Xiao X; Li S; Guo X
PLoS One; 2017; 12(1):e0170090. PubMed ID: 28081242
[TBL] [Abstract][Full Text] [Related]
30. A neurodegenerative perspective on mitochondrial optic neuropathies.
Yu-Wai-Man P; Votruba M; Burté F; La Morgia C; Barboni P; Carelli V
Acta Neuropathol; 2016 Dec; 132(6):789-806. PubMed ID: 27696015
[TBL] [Abstract][Full Text] [Related]
31. Clinical variability in hereditary optic neuropathies: Two novel mutations in two patients with dominant optic atrophy and Wolfram syndrome.
Galvez-Ruiz A
Saudi J Ophthalmol; 2015; 29(4):307-11. PubMed ID: 26586986
[TBL] [Abstract][Full Text] [Related]
32. OCT: New perspectives in neuro-ophthalmology.
Rebolleda G; Diez-Alvarez L; Casado A; Sánchez-Sánchez C; de Dompablo E; González-López JJ; Muñoz-Negrete FJ
Saudi J Ophthalmol; 2015; 29(1):9-25. PubMed ID: 25859135
[TBL] [Abstract][Full Text] [Related]
33. Distributed abnormalities of brain white matter architecture in patients with dominant optic atrophy and OPA1 mutations.
Rocca MA; Bianchi-Marzoli S; Messina R; Cascavilla ML; Zeviani M; Lamperti C; Milesi J; Carta A; Cammarata G; Leocani L; Lamantea E; Bandello F; Comi G; Falini A; Filippi M
J Neurol; 2015 May; 262(5):1216-27. PubMed ID: 25794858
[TBL] [Abstract][Full Text] [Related]
34. Diffusion Tensor Imaging Mapping of Brain White Matter Pathology in Mitochondrial Optic Neuropathies.
Manners DN; Rizzo G; La Morgia C; Tonon C; Testa C; Barboni P; Malucelli E; Valentino ML; Caporali L; Strobbe D; Carelli V; Lodi R
AJNR Am J Neuroradiol; 2015 Jul; 36(7):1259-65. PubMed ID: 25792533
[TBL] [Abstract][Full Text] [Related]
35. Medical management of hereditary optic neuropathies.
La Morgia C; Carbonelli M; Barboni P; Sadun AA; Carelli V
Front Neurol; 2014; 5():141. PubMed ID: 25132831
[TBL] [Abstract][Full Text] [Related]
36. Reply: Sensorineural hearing loss in OPA1-linked disorders.
Yu-Wai-Man P; Chinnery PF
Brain; 2013 Jul; 136(Pt 7):e237. PubMed ID: 23650221
[No Abstract] [Full Text] [Related]
37. The optic nerve: a "mito-window" on mitochondrial neurodegeneration.
Maresca A; la Morgia C; Caporali L; Valentino ML; Carelli V
Mol Cell Neurosci; 2013 Jul; 55(100):62-76. PubMed ID: 22960139
[TBL] [Abstract][Full Text] [Related]
38. Dominant optic atrophy.
Lenaers G; Hamel C; Delettre C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P; Milea D
Orphanet J Rare Dis; 2012 Jul; 7():46. PubMed ID: 22776096
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.
Yu-Wai-Man P; Griffiths PG; Chinnery PF
Prog Retin Eye Res; 2011 Mar; 30(2):81-114. PubMed ID: 21112411
[TBL] [Abstract][Full Text] [Related]
40. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size.
Barboni P; Carbonelli M; Savini G; Foscarini B; Parisi V; Valentino ML; Carta A; De Negri A; Sadun F; Zeviani M; Sadun AA; Schimpf S; Wissinger B; Carelli V
Ophthalmology; 2010 Aug; 117(8):1547-53. PubMed ID: 20417568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
